Company Performance Metrics
- Erik de Vries: Sr Director Business DevelopmentPast Role: Enzymicals, Chief Executive Officer
As industrial biotechnology specialists, BRAIN Biotech develops and produces enzymes, proteins, microbial production strains and bioactive natural products for industrial applications. In addition, the company´s innovative biosolutions help make industrial processes more sustainable. The company focuses on food & beverages, life science, and
environmental topics. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group and has been listed on the Prime Standard of the Frankfurt Stock Exchange since 9 February 2016 (ticker symbol: BNN).